ImmunityBio, Inc.
IBRX
$2.38
$0.135.78%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 153.66M | 61.59M | 149.81M | 130.37M | 217.98M |
| Total Receivables | 22.33M | 17.45M | 2.65M | 4.90M | 2.06M |
| Inventory | 6.64M | 8.44M | 8.27M | 1.96M | 1.81M |
| Prepaid Expenses | 15.85M | 13.62M | 16.73M | 15.21M | 11.33M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.65M | 8.05M | 7.12M | 10.71M | 9.65M |
| Total Current Assets | 208.13M | 109.16M | 184.59M | 163.15M | 242.83M |
|
|
|||||
| Total Current Assets | 208.13M | 109.16M | 184.59M | 163.15M | 242.83M |
| Net Property, Plant & Equipment | 168.03M | 167.05M | 170.46M | 174.23M | 175.79M |
| Long-term Investments | 910.00K | 910.00K | 910.00K | 910.00K | -- |
| Goodwill | 910.00K | 910.00K | 910.00K | 910.00K | -- |
| Total Other Intangibles | 14.07M | 14.53M | 15.02M | 15.57M | 16.06M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.24M | 11.40M | 11.96M | 10.71M | 9.65M |
| Total Assets | 402.08M | 303.76M | 382.93M | 364.57M | 444.33M |
|
|
|||||
| Total Accounts Payable | 7.42M | 13.50M | 6.73M | 9.95M | 20.32M |
| Total Accrued Expenses | 33.89M | 25.59M | 37.91M | 39.70M | 33.88M |
| Short-term Debt | -- | -- | 1.25M | 2.16M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.44M | 7.46M | 7.47M | 7.03M | 6.27M |
| Total Finance Division Other Current Liabilities | 1.90M | 2.66M | 1.60M | 2.12M | 1.65M |
| Total Other Current Liabilities | 1.90M | 2.66M | 1.60M | 2.12M | 1.65M |
| Total Current Liabilities | 50.64M | 49.21M | 54.94M | 60.96M | 62.11M |
|
|
|||||
| Total Current Liabilities | 50.64M | 49.21M | 54.94M | 60.96M | 62.11M |
| Long-Term Debt | 799.13M | 782.00M | 746.28M | 972.78M | 956.26M |
| Short-term Debt | -- | -- | 1.25M | 2.16M | -- |
| Capital Leases | 36.09M | 33.10M | 34.82M | 36.76M | 36.43M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 86.03M | 29.94M | 35.01M | 38.24M | 86.91M |
| Total Liabilities | 971.90M | 894.24M | 871.06M | 1.11B | 1.14B |
|
|
|||||
| Common Stock & APIC | 3.01B | 2.89B | 2.88B | 2.57B | 2.53B |
| Retained Earnings | -3.60B | -3.50B | -3.38B | -3.32B | -3.23B |
| Treasury Stock & Other | 12.57M | 19.96M | 1.20M | 103.00K | -8.00K |
| Total Common Equity | -570.75M | -591.43M | -489.10M | -745.15M | -698.39M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -570.75M | -591.43M | -489.10M | -745.15M | -698.39M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 930.00K | 949.00K | 969.00K | 986.00K | 1.01M |
| Total Equity | -569.82M | -590.48M | -488.13M | -744.16M | -697.38M |
|
|
|||||